FDA Files Supplemental Brief In Row Over Its Rules For Mifepristone Dispensing

( March 5, 2026, 9:14 AM EST) -- LAFAYETTE, La. — The federal government outlined the procedure for how the U.S. Food and Drug Administration can issue interim orders if it obtains information about drugs that have been previously approved in response to a request for supplemental briefs by the Louisiana federal judge overseeing a case brought by the state and one of its residents that challenges the validity of the FDA’s 2023 decision to remove the in-person dispensing requirement for mifepristone....